Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs

NCT00207064 is registered in ClinicalTrials.gov with Birte Glenthoj as lead sponsor.

NCT NCT00207064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs
Lead sponsor
Birte Glenthoj
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2004
Completion date
September 30, 2008
Enrollment
46 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia